S1N Stock Overview
Sunwin Stevia International, Inc. produces and sells natural sweeteners and other pharmaceutical products primarily in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Sunwin Stevia International, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.013 |
| 52 Week High | US$0.034 |
| 52 Week Low | US$0.012 |
| Beta | 1.25 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -59.38% |
| 3 Year Change | -76.79% |
| 5 Year Change | -86.17% |
| Change since IPO | -90.30% |
Recent News & Updates
Recent updates
Shareholder Returns
| S1N | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | -4.2% | -1.7% |
| 1Y | -59.4% | -32.1% | -0.2% |
Return vs Industry: S1N underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.
Return vs Market: S1N underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| S1N volatility | |
|---|---|
| S1N Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: S1N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine S1N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 242 | Chunchun Wang | www.sunwininternational.com |
Sunwin Stevia International, Inc. produces and sells natural sweeteners and other pharmaceutical products primarily in the People’s Republic of China. It operates through two segments, Stevioside; and Corporate and Other Pharmaceutical. The company produces and sells various steviol glycosides with rebaudioside A and stevioside as the principal components.
Sunwin Stevia International, Inc. Fundamentals Summary
| S1N fundamental statistics | |
|---|---|
| Market cap | €2.02m |
| Earnings (TTM) | -€2.60m |
| Revenue (TTM) | €37.14m |
0.1x
P/S Ratio-0.8x
P/E RatioIs S1N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| S1N income statement (TTM) | |
|---|---|
| Revenue | US$36.70m |
| Cost of Revenue | US$33.32m |
| Gross Profit | US$3.38m |
| Other Expenses | US$5.95m |
| Earnings | -US$2.57m |
Last Reported Earnings
Jul 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.013 |
| Gross Margin | 9.20% |
| Net Profit Margin | -7.01% |
| Debt/Equity Ratio | 293.8% |
How did S1N perform over the long term?
See historical performance and comparison